Browse by Title

Type here to filter the list

W
Waldenstrom

Steven Treon, MD, PhD, FACP, FRCP (he/him/his) – Dana Farber Cancer Institute ### 1395107###Speaker###Professor-Harvard Medical School, Director-Bing Center for WM###Dana Farber Cancer Institute###
Speaker: Steven Treon, MD, PhD, FACP, FRCP (he/him/his) – Dana Farber Cancer Institute
### he/him/his
Welcome and Introduction

Joseph Mikhael, MD – Translational Genomics Research Institute (TGen), City of Hope Cancer Center ### 1409001###Speaker###Professor in Applied Cancer Research and Drug Discovery###Translational Genomics Research Institute (TGen), City of Hope Cancer Center###
Speaker: Joseph Mikhael, MD – Translational Genomics Research Institute (TGen), City of Hope Cancer Center
###
Welcome and Introduction

Hermann Einsele, MD, FRCP (he/him/his) – Universitätsklinikum Würzburg, Medizinische Klinik und Poliklinik II, Würzburg, Germany ### 1395031###Speaker###Clinic Director of Medicine###Universitätsklinikum Würzburg, Medizinische Klinik und Poliklinik II, Würzburg, Germany###
Speaker: Hermann Einsele, MD, FRCP (he/him/his) – Universitätsklinikum Würzburg, Medizinische Klinik und Poliklinik II, Würzburg, Germany
### he/him/his
What is the ideal duration of treatment - MRD guided or till progression?

Kwee L. Yong, PhD (she/her/hers) – University College London Cancer Institute, London, UK ### 1395115###Speaker###Professor of Haematology###University College London Cancer Institute, London, UK###
Speaker: Kwee L. Yong, PhD (she/her/hers) – University College London Cancer Institute, London, UK
### she/her/hers
What is the optimal upfront therapy - 3 or 4 drugs?

Saad Z. Usmani, MD MBA FACP – Memorial Sloan Kettering Cancer Center ### 1395084###Speaker###Chief of Myeloma Service###Memorial Sloan Kettering Cancer Center###
Speaker: Saad Z. Usmani, MD MBA FACP – Memorial Sloan Kettering Cancer Center
###
Who needs an autologous stem cell transplant upfront?

Aurore Perrot, MD, PhD – CHU de Toulouse, IUCT-O, Université de Toulouse, UPS, Service d’Hématologie, Toulouse, France ### 1416883###Speaker###Professor###CHU de Toulouse, IUCT-O, Université de Toulouse, UPS, Service d’Hématologie, Toulouse, France###
Speaker: Aurore Perrot, MD, PhD – CHU de Toulouse, IUCT-O, Université de Toulouse, UPS, Service d’Hématologie, Toulouse, France
###